Synthesis method of acylated GLP-1 compound and modified gene thereof

A technology of GLP-1 and compound, applied in the field of synthesis of acylated GLP-1 compound and its modification group, can solve the problems of many racemic impurities, waste of raw materials, poor activity and the like

Inactive Publication Date: 2020-07-07
VONSUN PHARMATECH CO LTD +2
View PDF7 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method wastes raw materials, the obtained reaction intermediate needs to be purified, and a certain quality standard is established. Due to the increase in steps, complicated purification and detection, etc., the final synthesis cost increases; the second method is to insert the modified lysine The main chain of semaglutide, the defect of this method is incomplete reaction, poor activity, high production cost, multi-step purification...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis method of acylated GLP-1 compound and modified gene thereof
  • Synthesis method of acylated GLP-1 compound and modified gene thereof
  • Synthesis method of acylated GLP-1 compound and modified gene thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Synthesis of Compound 5:

[0058] Weigh 15.97g of 2-chlorotriphenyl chloride resin (sub=0.939mmol / g), add it to a solid-phase synthesis column, use Fmoc-AEEA-OH (1.5eq), DIPEA (4.5eq), solvent DCM, Reaction for 1.5h to obtain Fmoc-AEEA-resin, after synthesis, use 20% piperidine / DMF to deprotect, time: 5+15min;

[0059] When condensing the second AEEA, use a reaction system in which the molar ratio of 2-chlorotriphenyl chloride resin / Fmoc-AEEA-OH / HATU / DIPEA is 1:2:2:2.4, and react for 1.5h to obtain Fmoc-AEEA-AEEA- Resin, use 20% piperidine / DMF to deprotect after synthesis, the deprotection time is: 5+15min;

[0060] When condensing γ-Glu, use a reaction system in which the molar ratio of 2-chlorotriphenyl chloride resin / Fmoc-Glu(OH)-OtBu / HATU / DIPEA is 1:2:2:2.4, and react for 1.5h to obtain Fmoc-γ -Glu-AEEA-AEEA-resin, use 20% piperidine / DMF to deprotect after synthesis, the deprotection time is: 5+15min;

[0061] When condensing mono-tert-butyl octadecanedioate, use...

Embodiment 2

[0064] Synthesis of compound 6:

[0065] Weigh 13.96g of compound 5 (1.0eq) and 2.28g of N-hydroxysuccinimide (1.2eq), add 250mL of dichloromethane and stir to dissolve, add dropwise 4.09g of DCC (1.2eq) in 60ml of DCM solution under ice cooling After dropping, move to room temperature and stir the reaction. After reacting for 15 hours, filter and spin dry the filtrate to obtain a colorless transparent oil, add 430ml of acetonitrile and stir, a small amount of white solid precipitates, filter and spin dry the filtrate to obtain 16.50 g of compound 6 as a colorless oil, yield: 100%.

Embodiment 3

[0067] Synthesis of Compound 1:

[0068] Add 83mL TFA to 53mL DCM and mix well, and cool to 3-5 degrees Celsius, add it to 16.50g crude product of compound 6 under ice bath, then transfer to room temperature and stir for 1.5h, spin dry, add toluene to spin Steam (100mL*3) to obtain a brown oil. Add 300mL of diethyl ether under ice bath and stir to make a slurry, a large amount of white solid precipitates out, centrifuge, add diethyl ether to wash (400mL*3), dry to obtain 13.96g of white solid compound 1, yield: 100%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a synthesis method of an acylated GLP-1 compound and modified gene thereof. The synthesis method of the acylated GLP-1 compound and modified gene thereof is characterized by comprising the following steps of preparing a compound 2, namely, taking GLP-1 (9-37) as an initial raw material, carrying out PEG medication by a compound 1 on Lys of a position 26 of a relative sequence GLP-1 (9-37), controlling the reaction pH and carrying out an acylation coupling reaction to obtain a compound 2; preparing a compound 4, namely, taking the compound 2 as the initial raw material,carrying out modification of GLP-1 (9-37) end amino by a compound 3, and then carrying out a liquid phase acylation coupling reaction with a reaction condensing agent and alkali to obtain a compound4; an preparing Semaglutide, namely, taking the compound 4 as the initial raw material, carrying out deprotection to obtain final Semaglutide. The method is simple and convenient to operate, the sidereaction is reduced, the risk of racemization of the amino acid compound is greatly reduced, and the method has a wide application prospect and is convenient for large-scale production.

Description

technical field [0001] The invention relates to the synthesis of an acylated GLP-1 compound and a modification group thereof, belonging to the field of chemical synthesis. Background technique [0002] Semaglutide is a long-acting GLP-1 analog developed by Novo Nordisk that can be injected subcutaneously once a week. From the structural point of view, semaglutide is Aib at position 8 on the GLP-1 (7-37) chain replacing Ala, Arg at position 34 replacing Lys, Lys at position 26 is connected to octadecanoic acid fatty chain. Compared with liraglutide, semaglutide has a longer fatty chain and increased hydrophobicity. The hydrophilicity of semaglutide is greatly enhanced by short-chain polyethylene glycol (PEG) modification. After PEG modification, it can not only bind tightly with albumin, cover the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, prolong the biological half-life and achieve the effect of long circulation. PEG is the most commonly used modif...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K14/605C07K1/107C07K1/06C07K1/04
CPCC07K14/605
Inventor 辛中帅王琦芳文良柱钟远广张先勇李夷平
Owner VONSUN PHARMATECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap